Volume 10 - Issue 1

Mini Review Biomedical Science and Research Biomedical Science and Research CC by Creative Commons, CC-BY

Effect of Sr, Zn, and Ce Substitution on the Properties of Bioactive Glasses

*Corresponding author: Irina Atkinson, Institute of Physical Chemistry of the Romanian Academy Bucharest 202 Splaiul Independentei, 060021 Bucharest, Romania.

Received: July 29, 2020; Published: August 21, 2020

DOI: 10.34297/AJBSR.2020.10.001467

Abstract

As well as improving the life of people of all ages, a rise in the life expectancy of people has led to an increased demand for new restoring and augmentation materials that have applications in therapies for bone pathologies. Bioactive Glasses (BGs) have revolutionized the field of biomaterials as they have been generally accepted to be able to promote both hard and soft living tissues regeneration and self-repair. This brief review will discuss the effect of metallic ions substitution on the properties of bioactive glasses for tissue engineering and regenerative medicine applications.

Bioactive Glasses an Overview

The discovery and development of materials that interface with living host tissue i.e. fusion and co-joining of biomaterials with the human body are of great interest in the field of medical implants. A large amount of scientific effort has been devoted to find and manufacture biomaterials with improved properties. Traditionally, Bioactive Glasses (BGs) have been used to fill and restore bone defects. Recently, a high number of studies investigated and suggested BGs for bone replacement or skin repair and regeneration [1-5].

BGs are playing a fundamental role in the field of biomaterials due to their osteoconductive, osteo productive and osteo inductive properties. Prof. Hench [6], who initiated this subject of research with his colleagues in the early 1970s [6], gave us a good definition of bioactive materials; “A bioactive material is one that elicits a specific biological response at the interface of the material which results in the formation of a bond between the tissues and the material”, Hench and his research team discovered that a certain composition of glass in the system SiO2-CaO-Na2O-P2O5 was able to form a bond with bone once they are implanted. In fact, when these BGs are immersed biological fluids, a layer of Hydroxyapatite (HA) is deposited on their surface. The 45S5 bioactive glass composition, known as Bio glass (composition in wt.%: 45% SiO2, 24.5% Na2O, 24.5% CaO and 6% P2O5), has approval of the US Food and Drug Administration (FDA). 45S5Bioglassis used in clinical treatments of periodontal diseases as bone filler as well as in middle ear surgery [7].

Bioactive Glasses (BGs) can be produced either by a traditional melt-quenching method or a sol-gel route. Three main BG production techniques are of most interest. The melt quenching technique is the traditional technique for the production of BGs [8]. The synthesis includes melting oxides of i.e. silica, calcium, and phosphate in adequate proportions according to the desired composition at temperature of around 1300°C in a platinum crucible and quenched in a mold or in water (fritting procedure)-Annealing at 500°C of the quenched glass is required to remove the internal stresses from the glasses [8].

In the early 1990s BGs were for the first time prepared by the sol-gel process by Li et. al. [9] in an effort to overcome the limitations of melt derived BGs (synthesis at high temperature, lack of microporous structure, and a low specific surface) [10]. Porous bioactive glasses can be prepared from the hydrolysis and polymerization of metal alkoxides and/or organic or inorganic salts at low temperature. This synthesis method allows you to obtain materials with high specific surface area 200-650m2/g and high porosity [11]. In addition, due to the high surface area and porosity derived from the sol-gel process, the range of bioactive compositions is wider, and also exhibit higher bone bonding rates together with excellent degradation/resorption properties [12]. HA is deposited much faster on sol-gel BGs due to their higher porosity than on traditional melt derived glasses and these materials can be resorbed, in some cases [11]. In fact, the porous structure of gel bioactive glasses allows the formation of a hydrated layer inside the material, where biological moieties can enter maintaining their structural configuration and biological activity.

Sol-gel process can be combined with supramolecular chemistry of surfactants, resulting the third generation of highly ordered Mesoporous Bioactive Glasses (MBGs) [13,14]. The structure-directing agents used for fabrication of MBGs (CTAB, F127 and P123) influence the mesopore structure, mesopore size, surface area and pore volume of MBGs. MBGs can be used as multifunctional systems as a carrier for drugs, growth factors or other biomolecules. Moreover, BGs and MBGs can be foamed to produce macroporous scaffolds with interconnected macro pores enhancing the bioactive behaviour as well as the release of ionic products [15].

The drawback of current treatments (e.g. high cytotoxic effects of alkali containing BGs) [16,17] and the impact on healthcare costs have focused scientific efforts to develop alkali free bioactive glasses for applications in tissue engineering. In addition to SiO2, CaO, P2O5 other metallic ions can be incorporated in the glass composition to improve their properties and add new biological functions [18-22]. In this review, the progress in the use of several metallic ions Strontium (Sr), Zinc (Zn), and Cerium (Ce), on the therapeutic properties of BGs is highlighted.

Effect of Sr, Zn, and Ce incorporation on the properties of BGs

In recent years, new compositions of BGs with high bioactivity and new functionalities (e.g enhanced bone formation and angiogenesis, antimicrobial properties) induced by the ions release from the glass structure into the surrounding biological environment were produced [23-26]. The ionic dissolution of BGs stimulates the expression and secretion of biochemical markers: Osteocalcin (OCN), Osteopontin (OPN), and Vascular Endothelial Growth Factor (VEGF) involved in the repair and regeneration of bone [27].

Strontium (Sr) is a naturally occurring trace element in the human body. The total amount of strontium in the body is 0.335g of its Ca content [28]. The biological features of Sr are similar to Ca in the human body, both have strong bone-seeking properties [29,30]. Nowadays strontium is used as a commercial oral drug to treat osteoporosis by stimulating the formation of new bone and preventing osteoclast-mediated resorption [31]. Sr is the only element among the ones present in human bone that is correlated with bone compression strength [32]. Wu et al. [33] reported that the Sr containing mesoporous BG scaffolds stimulates the osteogenic differentiation of periodontal ligament cells, which clearly induced osteoblast activity.  Recent investigation has shown ability of Sr doped BGs obtained by sol-gel method to promote proliferation, early odontogenic differentiation and mineralization of human dental pulp cells [33].

Among doping elements, Zinc (Zn) has received special interest in the recent years due to its potential benefits. Zn is a cofactor for many enzymes, by stimulating protein synthesis which is essential in DNA replication. Furthermore, it has an important role in bone cell growth, development and differentiation [34-36]. Zinc deficiency can be associated with delay in bone tissue calcification and skeletal growth retardation [37]. Also, Zn has antibacterial activity and can have beneficial effect on the mechanical strength of the BGs [38]. Effect of the ZnO substitution on the biocompatibility of BGs has been studied by different research groups [18,39]. Sanchez-Salcedo et al. [40] reported antimicrobial activity against staphylococcus aureus and good biocompatibility of the scaffolds with 7mol% ZnO addition. Very good antimicrobial activity against P. aeruginosa and B. subtilis strains was achieved by Zn containing MGBs doped with 5% mole ZnO [18]. ZnO can act both as a network modifier or an intermediate oxide in the BG structure. By increasing the ZnO content its role is switched from a network modifier to an intermediate oxide and hence can influence BG properties. S. Shahrabi et al. [41] have shown that 5mol% ZnO may reduce the number of nonbridging oxygen atoms, and hence decrease the glass bioactivity [41]. Similar results were reported by [18].

In the last years cerium (Ce) has received special attention due to its beneficial biological features, antibacterial properties and in vitro positive effect on primary mouse osteoblasts [42,43].

Recently several studies reported the effects of the addition of Ce to the BG properties. Thus, Shruti et al [44] evaluated the bioactivity of scaffold based on Ce containing MBGs.  High content of cerium determines a decrease of BG bioactivity due to crystallization of CePO4 that came out and agglomerated on the surface of BG, impeding the formation of HA layer on the surface [45]. Recently, Atkinson et al. reported that increasing ceria content improves chemical durability of MBGs containing 5 moles% of ZnO and its bioactivity was not altering significantly (a deficient HAP was formed) [19]. Incorporation of cerium into BGs can enhance their antioxidant activity inducing anti-inflammatory, pro-osteogenesis, and pro angiogenesis activities [46].  V Nicolini [47] studied the catalase mimetic activity of Ce-containing BGs based on 45S5 composition and reported that these BGs have the ability to inhibit oxidative stress, by mimicking the catalase and superoxide dismutase activity. Good bioactivity and antibacterial response against Escherichia coli of BGs with 1, 5, 10 moles% CeO2 were reported by Goh et al. [42]. Beside its beneficial effects mentioned above, Ce also is known as a neuroprotective agent being involved in peripheral nerve regeneration [48].

Despite these advantages of ceria over other therapeutic strategies, there are still toxicity issues to be considered [49]. However, recent investigations have shown that MBGs containing Ce have no cell cytotoxic activity on L929 cells [19].

Conclusion

In this paper, the effect of the substitution of several key ions, including strontium, zinc, and cerium on BGs therapeutic properties was summarized. A large volume of research is focused on obtaining doped BGs with enhanced biological activity. These metallic ions are added to the BG formulation to impart therapeutic features, but they also can change the properties of BG, such as altering the bioactivity and rate of HA formation. Attractive biomaterials for tissue engineering applications can be obtained by incorporation of Sr, Zn and, Ce in their formulation.

References